Apyx Medical Corp
APYXNasdaqCIK 719135HealthcareFiscal year ends Dec 31
Reports and events: 290 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-01-0807:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-24-000003 |
| 2023-11-2816:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000719135-23-000066 |
| 2023-11-1617:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000719135-23-000063 |
| 2023-11-0916:49 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-23-040084 |
| 2023-11-0915:49 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000719135-23-000056 |
| 2023-11-0907:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-23-000054 |
| 2023-08-1615:52 ET | 8-K | 5.07 Shareholder vote results | 0000719135-23-000049 |
| 2023-08-1117:46 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000719135-23-000047 |
| 2023-08-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-23-000045 |
| 2023-06-2309:15 ET | DEF 14A | Proxy statementPeriod 2022-12-31 | 0000719135-23-000033 |
| 2023-05-1115:06 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000719135-23-000027 |
| 2023-05-1107:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-23-000025 |
| 2023-04-1817:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000719135-23-000022 |
| 2023-03-1616:07 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000719135-23-000018 |
| 2023-03-1607:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-23-000015 |
| 2023-03-1516:50 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000719135-23-000012 |
| 2023-02-2414:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000719135-23-000009 |
| 2023-01-1007:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-23-000002 |
| 2022-11-1015:20 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000719135-22-000091 |
| 2022-11-1007:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-22-000088 |
| 2022-08-1716:09 ET | 8-K | 5.07 Shareholder vote results | 0000719135-22-000080 |
| 2022-08-1117:11 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000719135-22-000063 |
| 2022-08-1116:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-22-000062 |
| 2022-07-1807:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000719135-22-000058 |
| 2022-06-2407:58 ET | DEF 14A | Proxy statementPeriod 2021-12-31 | 0000719135-22-000048 |
| 2022-06-1309:01 ET | 8-K | 8.01 Other events | 0000719135-22-000044 |
| 2022-05-2611:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000719135-22-000040 |
| 2022-05-1212:17 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000719135-22-000033 |
| 2022-05-1207:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-22-000030 |
| 2022-04-0407:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000719135-22-000026 |
| 2022-03-2116:22 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0000719135-22-000022 |
| 2022-03-1714:33 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000719135-22-000020 |
| 2022-03-1707:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-22-000018 |
| 2022-03-1407:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000719135-22-000015 |
| 2022-01-1009:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-22-000004 |
| 2021-11-1208:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-21-000074 |
| 2021-11-1208:08 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000719135-21-000072 |
| 2021-08-3008:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000719135-21-000068 |
| 2021-08-1214:11 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000719135-21-000064 |
| 2021-08-1210:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-21-000063 |
| 2021-08-0914:17 ET | 8-K | 5.07 Shareholder vote results | 0000719135-21-000044 |
| 2021-06-2509:02 ET | DEF 14A | Proxy statementPeriod 2020-12-31 | 0000719135-21-000040 |
| 2021-05-1214:13 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0000719135-21-000036 |
| 2021-05-1206:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-21-000033 |
| 2021-03-3116:31 ET | 10-K | Annual reportPeriod 2020-12-31 | 0000719135-21-000029 |
| 2021-03-3107:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-21-000027 |
| 2021-03-3017:10 ET | 8-K | 1.01 Entry into a material agreement | 0000719135-21-000024 |
| 2021-01-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000719135-21-000002 |
| 2020-11-1211:08 ET | 8-K | 1.01 Entry into a material agreement | 0000719135-20-000079 |
| 2020-11-0915:02 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0000719135-20-000076 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 13:09 ET. Listed shows no prices and gives no investment advice.